ReviewCancer gene therapy2025
Hemorrhagic and ischemic risks of anti-VEGF therapies in glioblastoma.
Ozal Beylerli et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ReviewCancer gene therapy2025
Ozal Beylerli et al.PubMed ↗Publisher ↗
No numbers read from the abstract.